If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change.
If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change, writes Peter Muller.
The lines between the pharma and food industries are blurring, presenting a great opportunity for life sciences firms to diversify - as long as they understand the regulatory differences, writes Peter Muller.